Ngenla 24 mg/1.2mL (Somatrogon-Ghla INJECTION, SOLUTION) 24 mg/1.2mL

Ngenla 24 mg/1.2mL is a somatrogon-ghla injection solution used for growth hormone therapy. This subcutaneous solution is designed to support growth in children with growth hormone deficiency. Learn more about Ngenla's uses and effects.

Strength

24 mg/1.2mL

Pack Size

1 CARTRIDGE in 1 CARTON (0069-0505-02) / 1.2 mL in 1 CARTRIDGE (0069-0505-01)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ngenla 24 mg/1.2mL is primarily used for growth hormone therapy in children who lack natural growth hormone production. This somatrogon-ghla injection solution is administered subcutaneously to help promote growth and development. The medication is often prescribed for children with growth hormone deficiency, a condition where the body does not produce enough growth hormone on its own. What is Ngenla used for? It is used to address growth issues related to hormone deficiencies.

Side Effects

Common effects of Ngenla 24 mg/1.2mL may include redness or swelling at the injection site. Some users might experience joint or muscle pain, headaches, or changes in appetite. These effects are generally mild and temporary, but it's important to monitor any persistent or severe reactions. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Ngenla 24 mg/1.2mL should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Avoid sharing the medication with others, and always check the expiration date before use. Proper disposal of used cartridges is essential to prevent accidental use or environmental contamination.

Avoid Interactions

Ngenla 24 mg/1.2mL may interact with other medications, including those that affect growth hormone levels or metabolism. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products. Alcohol and certain foods may also interact with the medication, so it's best to discuss any potential interactions with a healthcare professional.

Frequently Asked Questions

Ngenla 24 mg/1.2mL is used for growth hormone therapy in children with growth hormone deficiency.

Ngenla is administered subcutaneously using the provided cartridge and injection solution.

Common effects may include redness or swelling at the injection site, joint or muscle pain, headaches, or changes in appetite.

Ngenla may interact with other medications, so it's important to consult a healthcare provider before combining it with other treatments.

Ngenla should be stored according to the manufacturer's guidelines to maintain its effectiveness and safety.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.